Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Infection and Immunity|March 1, 1993
Laboratory and clinical evaluation of conjugate vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides bound to Pseudomonas aeruginosa recombinant exoprotein AA Fattom, R Schneerson, D C Watson, et al.
The New England Journal of Medicine|October 29, 1987
Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. A preliminary reportI L Acharya, C U Lowe, R Thapa, et al.
The Journal of Infectious Diseases|May 6, 1999
Safety and immunogenicity of Shigella sonnei and Shigella flexneri 2a O-specific polysaccharide conjugates in childrenS Ashkenazi, J H Passwell, E Harlev, et al.
Infection and Immunity|February 17, 2001
Safety and immunogenicity of improved Shigella O-specific polysaccharide-protein conjugate vaccines in adults in IsraelJ H Passwell, E Harlev, S Ashkenazi, et al.
The New England Journal of Medicine|April 26, 2001
The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old childrenF Y Lin, V A Ho, H B Khiem, et al.
Infection and Immunity|October 26, 1999
Safety and immunogenicity of Vi conjugate vaccines for typhoid fever in adults, teenagers, and 2- to 4-year-old children in VietnamZ Kossaczka, F Y Lin, V A Ho, et al.
Infection and Immunity|February 26, 2000
Phase 1 and phase 2 studies of Salmonella enterica serovar paratyphi A O-specific polysaccharide-tetanus toxoid conjugates in adults, teenagers, and 2- to 4-year-old children in VietnamE Y Konadu, F Y Lin, V A Hó, et al.
Pageof 3